Cerebrospinal fluid/serum immunoglobulin G quotient is predictive of unresponsiveness to intravenous methylprednisolone therapy for acute exacerbation of neuromyelitis optica spectrum disorder | Zendy

Okada Kazumasa | Zendy

Premium

Cerebrospinal fluid/serum immunoglobulin G quotient is predictive of unresponsiveness to intravenous methylprednisolone therapy for acute exacerbation of neuromyelitis optica spectrum disorder

Author(s) -

Okada Kazumasa

Publication year - 2016

Publication title -

clinical and experimental neuroimmunology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.297

H-Index - 15

ISSN - 1759-1961

DOI - 10.1111/cen3.12327

Subject(s) - plasmapheresis , neuromyelitis optica , cerebrospinal fluid , medicine , methylprednisolone , intravenous immunoglobulin therapy , exacerbation , antibody , immunology , immunoglobulin g

Oji et al. have reported that a high quotient of cerebrospinal fluid/serum immunoglobulin G might predict unresponsiveness to intravenous methylprednisolone and indicate the need for early introduction of plasmapheresis. The usefulness and problems regarding the quotient of cerebrospinal fluid/serum immunoglobulin G in clinical practice is discussed.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research